Cellumed Statistics

Total Valuation

Cellumed has a market cap or net worth of KRW 52.15 billion. The enterprise value is 53.00 billion.

Market Cap	52.15B
Enterprise Value	53.00B

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Cellumed has 54.95 million shares outstanding. The number of shares has increased by 17.25% in one year.

Current Share Class	54.95M
Shares Outstanding	54.95M
Shares Change (YoY)	+17.25%
Shares Change (QoQ)	+3.01%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	0.02%
Float	38.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.37
PB Ratio	4.11
P/TBV Ratio	4.25
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.69
EV / Sales	0.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.60

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.63.

Current Ratio	1.00
Quick Ratio	0.39
Debt / Equity	0.63
Debt / EBITDA	n/a
Debt / FCF	-0.99
Interest Coverage	-9.58

Financial Efficiency

Return on equity (ROE) is -143.28% and return on invested capital (ROIC) is -18.87%.

Return on Equity (ROE)	-143.28%
Return on Assets (ROA)	-8.06%
Return on Invested Capital (ROIC)	-18.87%
Return on Capital Employed (ROCE)	-63.55%
Revenue Per Employee	1.53B
Profits Per Employee	-337.45M
Employee Count	93
Asset Turnover	1.89
Inventory Turnover	18.09

Taxes

Income Tax	-265.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -45.65% in the last 52 weeks. The beta is 1.23, so Cellumed's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	-45.65%
50-Day Moving Average	998.78
200-Day Moving Average	1,958.09
Relative Strength Index (RSI)	42.41
Average Volume (20 Days)	1,514,913

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellumed had revenue of KRW 142.12 billion and -31.38 billion in losses. Loss per share was -620.49.

Revenue	142.12B
Gross Profit	7.62B
Operating Income	-9.67B
Pretax Income	-31.83B
Net Income	-31.38B
EBITDA	-8.61B
EBIT	-9.67B
Loss Per Share	-620.49

Full Income Statement

Balance Sheet

The company has 7.50 billion in cash and 7.99 billion in debt, giving a net cash position of -488.13 million or -8.88 per share.

Cash & Cash Equivalents	7.50B
Total Debt	7.99B
Net Cash	-488.13M
Net Cash Per Share	-8.88
Equity (Book Value)	12.68B
Book Value Per Share	224.06
Working Capital	-48.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.12 billion and capital expenditures -1.91 billion, giving a free cash flow of -8.03 billion.

Operating Cash Flow	-6.12B
Capital Expenditures	-1.91B
Free Cash Flow	-8.03B
FCF Per Share	-146.22

Full Cash Flow Statement

Margins

Gross margin is 5.36%, with operating and profit margins of -6.80% and -22.08%.

Gross Margin	5.36%
Operating Margin	-6.80%
Pretax Margin	-22.40%
Profit Margin	-22.08%
EBITDA Margin	-6.06%
EBIT Margin	-6.80%
FCF Margin	n/a

Dividends & Yields

Cellumed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.25%
Shareholder Yield	n/a
Earnings Yield	-60.18%
FCF Yield	-15.41%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 28, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

Cellumed has an Altman Z-Score of -0.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.21
Piotroski F-Score	2